Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases

A. Grankvist, PO. Andersson, M. Mattsson, M. Sender, K. Vaht, L. Höper, E. Sakiniene, E. Trysberg, M. Stenson, J. Fehr, S. Pekova, C. Bogdan, G. Bloemberg, C. Wennerås,

. 2014 ; 58 (12) : 1716-22.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15014463

BACKGROUND: Candidatus Neoehrlichia mikurensis is a newly discovered noncultivatable bacterium spread among ticks and rodents in Europe and Asia that can infect humans, particularly immunocompromised patients. METHODS: We compiled clinical and laboratory data from 11 patients with hematological malignances or autoimmune diseases who were diagnosed with Candidatus N. mikurensis infection in Europe 2010-2013. Both published (6) and unpublished cases (5) were included. RESULTS: The patients had a median age of 67, were mostly male (8/11), and resided in Sweden, Switzerland, Germany, and the Czech Republic. All but one had ongoing or recent immune suppressive treatment and a majority were splenectomized (8/11). Less than half of them recalled tick exposure. The most frequent symptoms were fever (11/11), localized pain afflicting muscles and/or joints (8/11), vascular and thromboembolic events (6/11), that is, deep vein thrombosis (4), transitory ischemic attacks (2), pulmonary embolism (1), and arterial aneurysm (1). Typical laboratory findings were elevated C-reactive protein, leukocytosis with neutrophilia, and anemia. Median time from onset of symptoms to correct diagnosis was 2 months. In at least 4 cases, the condition was interpreted to be due to the underlying disease, and immunosuppressive therapy was scheduled. All patients recovered completely when doxycycline was administered. CONCLUSIONS: Candidatus N. mikurensis is an emerging tick-borne pathogen that may give rise to a systemic inflammatory syndrome in persons with hematologic or autoimmune diseases that could be mistaken for recurrence of the underlying disease and/or unrelated arteriosclerotic vascular events. Awareness of this new pathogen is warranted among rheumatologists, hematologists, oncologists, and infectious disease specialists.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014463
003      
CZ-PrNML
005      
20150430090751.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/cid/ciu189 $2 doi
035    __
$a (PubMed)24647019
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Grankvist, Anna $u Department of Clinical Microbiology/Infectious Diseases, Sahlgrenska Academy, Sahlgrenska University Hospital, Göteborg.
245    10
$a Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases / $c A. Grankvist, PO. Andersson, M. Mattsson, M. Sender, K. Vaht, L. Höper, E. Sakiniene, E. Trysberg, M. Stenson, J. Fehr, S. Pekova, C. Bogdan, G. Bloemberg, C. Wennerås,
520    9_
$a BACKGROUND: Candidatus Neoehrlichia mikurensis is a newly discovered noncultivatable bacterium spread among ticks and rodents in Europe and Asia that can infect humans, particularly immunocompromised patients. METHODS: We compiled clinical and laboratory data from 11 patients with hematological malignances or autoimmune diseases who were diagnosed with Candidatus N. mikurensis infection in Europe 2010-2013. Both published (6) and unpublished cases (5) were included. RESULTS: The patients had a median age of 67, were mostly male (8/11), and resided in Sweden, Switzerland, Germany, and the Czech Republic. All but one had ongoing or recent immune suppressive treatment and a majority were splenectomized (8/11). Less than half of them recalled tick exposure. The most frequent symptoms were fever (11/11), localized pain afflicting muscles and/or joints (8/11), vascular and thromboembolic events (6/11), that is, deep vein thrombosis (4), transitory ischemic attacks (2), pulmonary embolism (1), and arterial aneurysm (1). Typical laboratory findings were elevated C-reactive protein, leukocytosis with neutrophilia, and anemia. Median time from onset of symptoms to correct diagnosis was 2 months. In at least 4 cases, the condition was interpreted to be due to the underlying disease, and immunosuppressive therapy was scheduled. All patients recovered completely when doxycycline was administered. CONCLUSIONS: Candidatus N. mikurensis is an emerging tick-borne pathogen that may give rise to a systemic inflammatory syndrome in persons with hematologic or autoimmune diseases that could be mistaken for recurrence of the underlying disease and/or unrelated arteriosclerotic vascular events. Awareness of this new pathogen is warranted among rheumatologists, hematologists, oncologists, and infectious disease specialists.
650    _2
$a senioři $7 D000368
650    _2
$a infekce bakteriemi čeledi Anaplasmataceae $x komplikace $x diagnóza $x farmakoterapie $7 D000711
650    _2
$a aneurysma $x mikrobiologie $7 D000783
650    _2
$a antibakteriální látky $x terapeutické užití $7 D000900
650    _2
$a autoimunitní nemoci $x mikrobiologie $7 D001327
650    _2
$a C-reaktivní protein $x metabolismus $7 D002097
650    _2
$a objevující se infekční nemoci $x diagnóza $x farmakoterapie $x mikrobiologie $7 D021821
650    _2
$a DNA bakterií $x krev $7 D004269
650    _2
$a opožděná diagnóza $7 D057210
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a horečka $x mikrobiologie $7 D005334
650    _2
$a hematologické nádory $x mikrobiologie $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a tranzitorní ischemická ataka $x mikrobiologie $7 D002546
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a muskuloskeletální bolest $x mikrobiologie $7 D059352
650    _2
$a plicní embolie $x mikrobiologie $7 D011655
650    _2
$a splenektomie $7 D013156
650    _2
$a nemoci přenášené klíšťaty $x komplikace $x diagnóza $x farmakoterapie $x mikrobiologie $7 D017282
650    _2
$a žilní trombóza $x mikrobiologie $7 D020246
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Andersson, Per-Ola $u Department of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg. $7 gn_A_00006217
700    1_
$a Mattsson, Mattias $u Department of Internal Medicine, Karlstad Hospital, Karlstad.
700    1_
$a Sender, Monica $u Department of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg.
700    1_
$a Vaht, Krista $u Department of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg.
700    1_
$a Höper, Linnea $u Department of Rheumatology, Sahlgrenska University Hospital, Göteborg.
700    1_
$a Sakiniene, Egidija $u Department of Rheumatology, Sahlgrenska University Hospital, Göteborg.
700    1_
$a Trysberg, Estelle $u Department of Rheumatology, Sahlgrenska University Hospital, Göteborg.
700    1_
$a Stenson, Martin $u Department of Medicine, Kungälv Hospital, Kungälv, Sweden.
700    1_
$a Fehr, Jan $u Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
700    1_
$a Pekova, Sona $u Laboratory for Molecular Diagnostics, CHAMBON Laboratories, Prague, Czech Republic.
700    1_
$a Bogdan, Christian $u Mikrobiologische Institut-Klinische Mikrobiologie, Immunologie und Hygiene, Friedrich Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
700    1_
$a Bloemberg, Guido $u Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
700    1_
$a Wennerås, Christine $u Department of Clinical Microbiology/Infectious Diseases, Sahlgrenska Academy, Sahlgrenska University Hospital, Göteborg Department of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg.
773    0_
$w MED00001133 $t Clinical infectious diseases $x 1537-6591 $g Roč. 58, č. 12 (2014), s. 1716-22
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24647019 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150430091056 $b ABA008
999    __
$a ok $b bmc $g 1072044 $s 897341
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 58 $c 12 $d 1716-22 $i 1537-6591 $m Clinical infectious diseases $n Clin Infect Dis $x MED00001133
LZP    __
$a Pubmed-20150420

Find record

Citation metrics

Archiving options